ASP Isotopes Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St

April 02, 2025

ASP Isotopes (NASDAQ:ASPI) Full Year 2024 Results

Key Financial Results

Net loss: US$35.1m (loss widened by 116% from FY 2023).
US$0.63 loss per share (further deteriorated from US$0.49 loss in FY 2023).

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

earnings-and-revenue-growth — NasdaqCM:ASPI Earnings and Revenue Growth April 2nd 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

ASP Isotopes Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 1.1%. Earnings per share (EPS) missed analyst estimates by 11%.

Looking ahead, revenue is forecast to grow 40% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in the US.

Performance of the American Chemicals industry.

The company's shares are up 5.9% from a week ago.

Risk Analysis

We should say that we've discovered 3 warning signs for ASP Isotopes (2 shouldn't be ignored!) that you should be aware of before investing here.

Mobile Infrastructure for Defense and Disaster

The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.

Get the investor briefing before the next round of contracts

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.